F344/DuCrl |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
9 |
|
|
1.45 |
beats/min |
8.08 |
24.25 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51261 |
481 |
F344/DuCrl |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
9 |
|
|
5.85 |
beats/min |
9.6 |
28.81 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51263 |
481 |
SS/JrHsdMcwi |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
urine sodium amount |
male |
87 days-120 days |
20 |
|
|
1.46 |
mEq/d |
0.2 |
0.9 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51266 |
481 |
GH/OmrMcwi |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
urine sodium amount |
male |
87 days-120 days |
8 |
|
|
1.32 |
mEq/d |
0.09 |
0.25 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51272 |
481 |
BN/NHsdMcwi |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
urine sodium amount |
male |
87 days-120 days |
3 |
|
|
0.95 |
mEq/d |
0.15 |
0.26 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51275 |
481 |
Hsd:SD |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
male |
87 days-120 days |
11 |
|
|
0.32 |
mg/dl |
0.03 |
0.11 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
51277 |
481 |
SS-Chr 20BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
female |
87 days-120 days |
11 |
|
|
0.32 |
mg/dl |
0.02 |
0.06 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51311 |
481 |
SS-Chr 9BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
female |
87 days-120 days |
13 |
|
|
0.32 |
mg/dl |
0.01 |
0.03 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51317 |
481 |
SS-Chr 16BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
7 |
|
|
108.35 |
mmHg |
1.6 |
4.22 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51328 |
481 |
SS-Chr 18BN/Mcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
5 |
|
|
394.09 |
beats/min |
7.89 |
17.63 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51379 |
481 |
SS-Chr 16BN/Mcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
5 |
|
|
423.79 |
beats/min |
7.38 |
16.5 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51382 |
481 |
Hsd:SD |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
14 |
|
|
8.24 |
beats/min |
8.8 |
32.91 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
51401 |
481 |
F344/DuCrl |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
9 |
|
|
-5.54 |
mmHg |
2.16 |
6.48 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51066 |
481 |
SS/JrHsdMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
18 |
|
|
-17.17 |
beats/min |
7.62 |
32.34 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51088 |
481 |
SS-Chr 16BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
10 |
|
|
21.46 |
beats/min |
11.94 |
37.77 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51091 |
481 |
SS-Chr 16BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
5 |
|
|
-5.64 |
mmHg |
2.48 |
5.55 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50764 |
481 |
SS-Chr 18BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
3 |
|
|
-6.83 |
mmHg |
2.51 |
4.35 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50765 |
481 |
SS-Chr 18BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
male |
87 days-120 days |
7 |
|
|
0.35 |
mg/dl |
0.01 |
0.02 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51171 |
481 |
SHR/NCrl |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
male |
87 days-120 days |
5 |
|
|
0.32 |
mg/dl |
0.01 |
0.01 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51181 |
481 |
GH/OmrMcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
male |
87 days-120 days |
8 |
|
|
0.31 |
mg/dl |
0.01 |
0.02 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51182 |
481 |
SS-Chr 16BN/Mcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
6 |
|
|
390.2 |
beats/min |
8.98 |
21.99 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51246 |
481 |
SHR/NCrl |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
8 |
|
|
321.19 |
beats/min |
5.4 |
15.26 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51249 |
481 |
FHH/EurMcwi |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
urine sodium amount |
female |
87 days-120 days |
8 |
|
|
0.91 |
mEq/d |
0.16 |
0.46 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51515 |
481 |
SS/JrHsdMcwi |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
urine sodium amount |
male |
87 days-120 days |
20 |
|
|
1.21 |
mEq/d |
0.14 |
0.65 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51516 |
481 |
BN/NHsdMcwi |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
female |
87 days-120 days |
2 |
|
|
1.55 |
ml/min |
0.17 |
0.24 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51548 |
481 |
GH/OmrMcwi |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
male |
87 days-120 days |
8 |
|
|
2.13 |
ml/min |
0.12 |
0.33 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51551 |
481 |
FHH/EurMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
4 |
|
|
7.64 |
beats/min |
18.08 |
36.17 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50976 |
481 |
GH/OmrMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
8 |
|
|
14.04 |
beats/min |
6.89 |
19.49 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50983 |
481 |
BN/NHsdMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
5 |
|
|
-28.94 |
beats/min |
6.27 |
14.02 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50988 |
481 |
FHH/EurMcwi |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
renin activity |
female |
87 days-120 days |
5 |
|
|
12.61 |
ng/ml/h |
1.89 |
4.23 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51002 |
481 |
SS-Chr 18BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
renin activity |
female |
87 days-120 days |
3 |
|
|
1.67 |
ng/ml/h |
0.55 |
0.96 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51006 |
481 |
SS-Chr 20BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
renin activity |
male |
87 days-120 days |
9 |
|
|
1.9 |
ng/ml/h |
0.26 |
0.78 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51012 |
481 |
BN/NHsdMcwi |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
renin activity |
male |
87 days-120 days |
1 |
|
|
8.99 |
ng/ml/h |
|
|
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51014 |
481 |
BN/NHsdMcwi |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
renin activity |
female |
87 days-120 days |
3 |
|
|
7.64 |
ng/ml/h |
1.68 |
2.91 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51015 |
481 |
SS-Chr 18BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
urine sodium amount |
male |
87 days-120 days |
6 |
|
|
1.16 |
mEq/d |
0.25 |
0.62 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51044 |
481 |
SS-Chr 18BN/Mcwi |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
female |
87 days-120 days |
4 |
|
|
1.03 |
ml/min |
0.2 |
0.41 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51055 |
481 |
BN/NHsdMcwi |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
male |
87 days-120 days |
3 |
|
|
1.39 |
ml/min |
0.23 |
0.41 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51063 |
481 |
SHR/NCrl |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
6 |
|
|
380.26 |
beats/min |
6.27 |
15.36 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50886 |
481 |
SS-Chr 20BN/Mcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
14 |
|
|
429.29 |
beats/min |
17.71 |
66.26 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50887 |
481 |
SS-Chr 16BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
7 |
|
|
4.05 |
beats/min |
12.42 |
32.85 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50909 |
481 |
BN/NHsdMcwi |
absolute change in mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then angiotensin II (200 ng/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
20 |
|
serial mean |
27.0 |
mmHg |
2.0 |
8.94 |
vascular indwelling catheter method |
left femoral artery |
0.0 |
|
0 |
|
|
|
|
67299 |
151 |
BN/NHsdMcwi |
absolute change in mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then NG-nitroarginine methyl ester (5 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
20 |
|
serial mean |
25.0 |
mmHg |
3.0 |
13.42 |
vascular indwelling catheter method |
left femoral artery |
0.0 |
|
0 |
|
|
|
|
67303 |
151 |
WKY/NCrl |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
9 |
|
|
336.79 |
beats/min |
11.9 |
35.71 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
|
51780 |
481 |
BN/NHsdMcwi |
systolic blood pressure |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
92 days-94 days |
14 |
|
serial mean |
110.0 |
mmHg |
3.0 |
11.22 |
vascular indwelling catheter method |
left femoral artery |
0 |
|
0 |
|
|
|
|
65462 |
151 |
SS/JrHsdMcwi |
systolic blood pressure |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
92 days-94 days |
12 |
|
serial mean |
160.0 |
mmHg |
6.0 |
20.78 |
vascular indwelling catheter method |
left femoral artery |
0 |
|
0 |
|
|
|
|
65463 |
151 |
BN/NHsdMcwi |
diastolic blood pressure |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
92 days-94 days |
14 |
|
serial mean |
72.0 |
mmHg |
2.0 |
7.48 |
vascular indwelling catheter method |
left femoral artery |
0 |
|
0 |
|
|
|
|
65464 |
151 |
SS/JrHsdMcwi |
diastolic blood pressure |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
92 days-94 days |
12 |
|
serial mean |
126.0 |
mmHg |
5.0 |
17.32 |
vascular indwelling catheter method |
left femoral artery |
0 |
|
0 |
|
|
|
|
65465 |
151 |
WKY/NCrl |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
9 |
|
|
-11.5 |
beats/min |
9.79 |
29.36 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
|
52064 |
481 |
LEW/Crl |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
5 |
|
|
-16.77 |
beats/min |
3.09 |
6.9 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
|
52065 |
481 |
FHH/EurMcwi |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
renin activity |
female |
87 days-120 days |
6 |
|
|
13.14 |
ng/ml/h |
1.17 |
2.86 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50567 |
481 |
SS-Chr 18BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
7 |
|
|
-21.19 |
mmHg |
2.27 |
6.01 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50625 |
481 |
SHR/NCrl |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
7 |
|
|
-23.04 |
mmHg |
2.62 |
6.92 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50634 |
481 |
BN/NHsdMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
1 |
|
|
5.59 |
mmHg |
|
|
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50636 |
481 |
BN/NHsdMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
3 |
|
|
-2.03 |
mmHg |
7.23 |
12.52 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50637 |
481 |
WKY/NCrl |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
renin activity |
male |
87 days-120 days |
8 |
|
|
6.96 |
ng/ml/h |
0.75 |
2.12 |
radioimmunoassay |
|
|
|
0 |
|
|
|
|
51957 |
481 |
SS-Chr 20BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
13 |
|
|
124.79 |
mmHg |
2.58 |
9.3 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51998 |
481 |
GH/OmrMcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
9 |
|
|
160.79 |
mmHg |
5.64 |
16.93 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51999 |
481 |
FHH/EurMcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
4 |
|
|
137.89 |
mmHg |
7.62 |
15.25 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
52007 |
481 |
WKY/NCrl |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
female |
87 days-120 days |
5 |
|
|
0.42 |
mg/dl |
0.03 |
0.07 |
radioimmunoassay |
|
|
|
0 |
|
|
|
|
50412 |
481 |
BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then angiotensin II (100 ng/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
21 |
|
serial mean |
132.9 |
mmHg |
3.8 |
17.41 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
0 |
|
|
|
|
69531 |
151 |
BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then acetylcholine (0.1 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
21 |
|
serial mean |
111.3 |
mmHg |
4.6 |
21.08 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
0 |
|
|
|
|
69541 |
151 |
BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then NG-nitroarginine methyl ester (5 mg/kg) then acetylcholine (0.1 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
21 |
|
serial mean |
138.6 |
mmHg |
3.8 |
17.41 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
0 |
|
|
|
|
69547 |
151 |
BN/NHsdMcwi |
plasma creatinine level |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
blood creatinine amount |
female |
92 days-94 days |
8 |
|
|
0.42 |
mg/dl |
0.11 |
0.31 |
plasma creatinine analysis |
|
0.0 |
|
0 |
|
urine potassium analysis |
umol/min |
|
69485 |
151 |
SS/JrHsdMcwi |
timed urine volume |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
urine output |
female |
92 days-94 days |
15 |
|
|
7.8 |
ml/d |
0.6 |
2.32 |
urine volume measurement method |
|
0.0 |
|
0 |
|
|
needs ml/d default |
|
69465 |
151 |
SS/JrHsdMcwi |
urine potassium excretion rate |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
urine potassium amount |
female |
92 days-94 days |
14 |
|
|
0.92 |
mEq/d |
0.07 |
0.27 |
unspecified method |
|
0.0 |
|
0 |
|
urine potassium analysis |
umol/min |
|
69474 |
151 |
WKY |
heart left ventricle infarction size to total heart left ventricle size ratio |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ramipril (1 mg/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle integrity trait |
male |
266 days-280 days |
32 |
|
|
30.9 |
% |
8.1 |
45.82 |
ex vivo microscopy with digital image analysis |
|
0.0 |
lad occlusion |
210 |
days |
|
|
|
100266 |
2460 |
WKY |
heart rate |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ramipril (1 mg/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart pumping trait |
male |
266 days-280 days |
32 |
|
|
373.0 |
beats/min |
15.0 |
84.85 |
echocardiography |
|
0.0 |
lad occlusion |
210 |
days |
|
|
|
100314 |
2460 |
WKY |
serum potassium level |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
blood potassium amount |
male |
266 days-280 days |
16 |
|
|
5.0 |
mmol/l |
0.19 |
0.76 |
automated serum potassium test |
|
0.0 |
lad occlusion |
210 |
days |
|
|
|
100334 |
2460 |
WKY |
heart ventricle septal wall thickness |
left anterior descending coronary artery occlusion (for 196 days) then furosemide (10 ml/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle wall thickness |
male |
238 days-252 days |
20 |
|
|
0.13 |
cm |
0.03 |
0.13 |
echocardiography |
|
0.0 |
lad occlusion |
196 |
days |
|
|
|
100337 |
2460 |
WKY |
heart posterior wall thickness |
left anterior descending coronary artery occlusion (for 196 days) then furosemide (10 ml/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle posterior wall thickness |
male |
238 days-252 days |
20 |
|
|
0.17 |
cm |
0.01 |
0.04 |
echocardiography |
|
0.0 |
lad occlusion |
196 |
days |
|
|
|
100346 |
2460 |
WKY |
ejection fraction |
left anterior descending coronary artery occlusion (for 196 days) then furosemide (10 ml/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
cardiac output trait |
male |
238 days-252 days |
20 |
|
|
35.5 |
% |
2.0 |
8.94 |
echocardiography |
|
0.0 |
lad occlusion |
196 |
days |
|
|
|
100352 |
2460 |
FHH/EurMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
4 |
|
|
2.03 |
mmHg |
7.31 |
14.61 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50811 |
481 |
FHH/EurMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
10 |
|
|
-2.98 |
mmHg |
0.76 |
2.39 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50635 |
481 |
FHH/EurMcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
4 |
|
|
387.54 |
beats/min |
13.35 |
26.69 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50888 |
481 |
BN/NHsdMcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
4 |
|
|
392.72 |
beats/min |
8.3 |
16.6 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50890 |
481 |
SS/JrHsdMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
5 |
|
|
8.29 |
beats/min |
21.22 |
47.46 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50905 |
481 |
Hsd:SD |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
male |
87 days-120 days |
9 |
|
|
1.85 |
ml/min |
0.15 |
0.44 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
51402 |
481 |
SHR/NCrl |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
urine sodium amount |
female |
87 days-120 days |
9 |
|
|
1.03 |
mEq/d |
0.18 |
0.54 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51524 |
481 |
SS-Chr 16BN/Mcwi |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
male |
87 days-120 days |
7 |
|
|
1.93 |
ml/min |
0.1 |
0.27 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51546 |
481 |
SHR/NCrl |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
urine sodium amount |
male |
87 days-120 days |
10 |
|
|
1.46 |
mEq/d |
0.11 |
0.36 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51270 |
481 |
SHR/NCrl |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
male |
87 days-120 days |
5 |
|
|
0.28 |
mg/dl |
0.01 |
0.03 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51315 |
481 |
SS-Chr 16BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
5 |
|
|
108.6 |
mmHg |
0.71 |
1.58 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51326 |
481 |
FHH/EurMcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
6 |
|
|
147.84 |
mmHg |
6.57 |
16.08 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51329 |
481 |
SS-Chr 16BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
renin activity |
male |
87 days-120 days |
8 |
|
|
3.34 |
ng/ml/h |
0.14 |
0.39 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50393 |
481 |
F344/DuCrl |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
9 |
|
|
111.8 |
mmHg |
2.06 |
6.17 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51732 |
481 |
Hsd:SD |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
12 |
|
|
114.44 |
mmHg |
1.98 |
6.87 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
51788 |
481 |
BN/NHsdMcwi |
plasma total cholesterol level |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
blood cholesterol amount |
female |
92 days-94 days |
10 |
|
|
56.0 |
mg/dl |
2.1 |
6.64 |
plasma total cholesterol measurement test |
|
0.0 |
|
0 |
|
|
|
|
67289 |
151 |
WKY/NCrl |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
6 |
|
|
-1.91 |
mmHg |
2.6 |
6.36 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
|
51917 |
481 |
GH/OmrMcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
8 |
|
|
181.05 |
mmHg |
7.86 |
22.24 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
52003 |
481 |
BN/NHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
5 |
|
|
91.89 |
mmHg |
3.36 |
7.51 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
52008 |
481 |
BN/NHsdMcwi |
urine sodium level |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
urine sodium amount |
female |
92 days-94 days |
22 |
|
|
100.4 |
mmol/l |
6.5 |
30.49 |
unspecified method |
|
0.0 |
|
0 |
|
urine sodium analysis |
|
|
69466 |
151 |
SS/JrHsdMcwi |
urine potassium level |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
urine potassium amount |
female |
92 days-94 days |
14 |
|
|
124.4 |
mmol/l |
8.8 |
32.93 |
unspecified method |
|
0.0 |
|
0 |
|
urine potassium analysis |
|
|
69472 |
151 |
WKY |
body weight |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ramipril (1 mg/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
body mass |
male |
266 days-280 days |
32 |
|
|
574.0 |
g |
38.0 |
214.96 |
body weighing method |
|
0.0 |
lad occlusion |
210 |
days |
|
|
|
100275 |
2460 |
WKY |
heart left ventricle weight |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle mass |
male |
266 days-280 days |
16 |
|
|
1.04 |
g |
0.13 |
0.51 |
post excision weight measurement |
|
0.0 |
lad occlusion |
210 |
days |
|
|
|
100292 |
2460 |
WKY |
ejection fraction |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
cardiac output trait |
male |
266 days-280 days |
16 |
|
|
38.5 |
% |
3.2 |
12.8 |
echocardiography |
|
0.0 |
lad occlusion |
210 |
days |
|
|
|
100301 |
2460 |
WKY |
heart rate |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart pumping trait |
male |
266 days-280 days |
16 |
|
|
362.0 |
beats/min |
31.0 |
124.0 |
echocardiography |
|
0.0 |
lad occlusion |
210 |
days |
|
|
|
100313 |
2460 |
WKY |
serum potassium level |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ramipril (1 mg/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
blood potassium amount |
male |
266 days-280 days |
32 |
|
|
4.9 |
mmol/l |
0.1 |
0.57 |
automated serum potassium test |
|
0.0 |
lad occlusion |
210 |
days |
|
|
|
100335 |
2460 |
SS/JrHsdMcwi |
absolute change in mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then norepinephrine (3 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
13 |
|
serial mean |
39.0 |
mmHg |
6.0 |
21.63 |
vascular indwelling catheter method |
left femoral artery |
0.0 |
|
0 |
|
|
|
|
67302 |
151 |
Crl:CD(SD) |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
5 |
|
|
-2.18 |
mmHg |
2.36 |
5.28 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51067 |
481 |
GH/OmrMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
8 |
|
|
0.56 |
beats/min |
2.95 |
8.35 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51094 |
481 |
BN/NHsdMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
3 |
|
|
-11.61 |
beats/min |
15.08 |
26.12 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51098 |
481 |
SS-Chr 18BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
5 |
|
|
-6.56 |
beats/min |
8.43 |
18.85 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50980 |
481 |
SS-Chr 9BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
13 |
|
|
8.0 |
beats/min |
11.17 |
40.27 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50981 |
481 |
SS-Chr 20BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
14 |
|
|
37.45 |
beats/min |
19.76 |
73.94 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50986 |
481 |
FHH/EurMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
4 |
|
|
36.95 |
beats/min |
7.33 |
14.67 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50987 |
481 |
BN/NHsdMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
4 |
|
|
-5.24 |
beats/min |
10.35 |
20.69 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50989 |
481 |
GH/OmrMcwi |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
renin activity |
female |
87 days-120 days |
9 |
|
|
3.39 |
ng/ml/h |
0.88 |
2.65 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51005 |
481 |
SHR/NCrl |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
renin activity |
male |
87 days-120 days |
5 |
|
|
6.62 |
ng/ml/h |
1.19 |
2.66 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51008 |
481 |
FHH/EurMcwi |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
urine sodium amount |
female |
87 days-120 days |
8 |
|
|
1.37 |
mEq/d |
0.05 |
0.15 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51046 |
481 |
SS-Chr 16BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
urine sodium amount |
female |
87 days-120 days |
6 |
|
|
1.16 |
mEq/d |
0.02 |
0.04 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51047 |
481 |
FHH/EurMcwi |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
female |
87 days-120 days |
5 |
|
|
1.14 |
ml/min |
0.11 |
0.24 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51051 |
481 |
GH/OmrMcwi |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
female |
87 days-120 days |
9 |
|
|
0.71 |
ml/min |
0.07 |
0.2 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51054 |
481 |
SHR/NCrl |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
female |
87 days-120 days |
4 |
|
|
0.59 |
ml/min |
0.17 |
0.33 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51060 |
481 |
GH/OmrMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
9 |
|
|
-11.35 |
mmHg |
4.78 |
14.34 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50803 |
481 |
SS-Chr 20BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
14 |
|
|
-15.73 |
mmHg |
1.65 |
6.17 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50810 |
481 |
BN/NHsdMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
5 |
|
|
-7.15 |
mmHg |
2.83 |
6.32 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50812 |
481 |
Hsd:SD |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
12 |
|
|
397.17 |
beats/min |
12.82 |
44.43 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
50814 |
481 |
LEW/Crl |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
5 |
|
|
97.54 |
mmHg |
1.66 |
3.71 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
|
50837 |
481 |
LEW/Crl |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
4 |
|
|
96.06 |
mmHg |
2.3 |
4.61 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
|
50838 |
481 |
FHH/EurMcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
5 |
|
|
389.31 |
beats/min |
12.58 |
28.14 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50877 |
481 |
GH/OmrMcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
9 |
|
|
419.89 |
beats/min |
5.87 |
17.6 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50880 |
481 |
BN/NHsdMcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
5 |
|
|
375.46 |
beats/min |
8.18 |
18.29 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50889 |
481 |
Hsd:SD |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
female |
87 days-120 days |
13 |
|
|
1.09 |
ml/min |
0.1 |
0.37 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
51403 |
481 |
SS-Chr 18BN/Mcwi |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
female |
87 days-120 days |
2 |
|
|
0.73 |
ml/min |
0.02 |
0.02 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51451 |
481 |
SS-Chr 18BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
5 |
|
|
-18.8 |
mmHg |
3.71 |
8.29 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50761 |
481 |
FHH/EurMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
5 |
|
|
-2.84 |
mmHg |
7.8 |
17.44 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50800 |
481 |
SS-Chr 18BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
urine sodium amount |
female |
87 days-120 days |
7 |
|
|
0.91 |
mEq/d |
0.11 |
0.28 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51519 |
481 |
SS-Chr 18BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
female |
87 days-120 days |
2 |
|
|
0.37 |
mg/dl |
0.07 |
0.09 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51537 |
481 |
FHH/EurMcwi |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
female |
87 days-120 days |
7 |
|
|
1.45 |
ml/min |
0.17 |
0.46 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51542 |
481 |
SHR/NCrl |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
female |
87 days-120 days |
7 |
|
|
0.29 |
mg/dl |
0.01 |
0.02 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51175 |
481 |
GH/OmrMcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
female |
87 days-120 days |
3 |
|
|
0.28 |
mg/dl |
0.01 |
0.02 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51176 |
481 |
FHH/EurMcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
7 |
|
|
431.85 |
beats/min |
7.73 |
20.45 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51244 |
481 |
SS-Chr 18BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
urine sodium amount |
male |
87 days-120 days |
8 |
|
|
1.25 |
mEq/d |
0.15 |
0.43 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51264 |
481 |
SS-Chr 16BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
urine sodium amount |
female |
87 days-120 days |
6 |
|
|
1.4 |
mEq/d |
0.14 |
0.34 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51267 |
481 |
SS-Chr 20BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
male |
87 days-120 days |
10 |
|
|
0.35 |
mg/dl |
0.01 |
0.03 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51319 |
481 |
FHH/EurMcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
7 |
|
|
133.34 |
mmHg |
4.01 |
10.6 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51325 |
481 |
SS/JrHsdMcwi |
absolute change in mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then angiotensin II (200 ng/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
13 |
|
serial mean |
34.0 |
mmHg |
3.0 |
10.82 |
vascular indwelling catheter method |
left femoral artery |
0.0 |
|
0 |
|
|
|
|
67300 |
151 |
LEW/Crl |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
5 |
|
|
380.88 |
beats/min |
3.51 |
7.84 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
|
51781 |
481 |
WKY/NCrl |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
6 |
|
|
390.89 |
beats/min |
8.33 |
20.42 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
|
51783 |
481 |
BN/NHsdMcwi |
plasma renin activity level |
controlled sodium content diet (0.4 %) (for 35 days) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
renin activity |
female |
95 days
| 11 |
|
|
9.6 |
ng/ml/h |
1.0 |
3.32 |
ex vivo blood analysis |
|
0 |
|
0 |
|
|
|
|
65474 |
151 |
SS-Chr 16BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
6 |
|
|
129.19 |
mmHg |
3.08 |
7.55 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51822 |
481 |
GH/OmrMcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
8 |
|
|
146.56 |
mmHg |
2.45 |
6.94 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51827 |
481 |
LEW/Crl |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
renin activity |
male |
87 days-120 days |
4 |
|
|
4.31 |
ng/ml/h |
1.53 |
3.06 |
radioimmunoassay |
|
|
|
0 |
|
|
|
|
51959 |
481 |
WKY/NCrl |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
renin activity |
female |
87 days-120 days |
6 |
|
|
6.9 |
ng/ml/h |
2.37 |
5.82 |
radioimmunoassay |
|
|
|
0 |
|
|
|
|
51960 |
481 |
SS-Chr 9BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
13 |
|
|
121.91 |
mmHg |
2.36 |
8.51 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
52001 |
481 |
SS-Chr 20BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
14 |
|
|
122.5 |
mmHg |
2.84 |
10.64 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
52006 |
481 |
BN/NHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
4 |
|
|
91.79 |
mmHg |
3.28 |
6.56 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
52009 |
481 |
LEW/Crl |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
male |
87 days-120 days |
4 |
|
|
2.35 |
ml/min |
0.29 |
0.57 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
|
52029 |
481 |
SS-Chr 18BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
renin activity |
male |
87 days-120 days |
5 |
|
|
2.8 |
ng/ml/h |
0.87 |
1.94 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50565 |
481 |
FHH/EurMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
7 |
|
|
-3.9 |
mmHg |
1.51 |
3.99 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50626 |
481 |
GH/OmrMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
8 |
|
|
-17.3 |
mmHg |
2.31 |
6.52 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50633 |
481 |
FHH/EurMcwi |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
renin activity |
male |
87 days-120 days |
9 |
|
|
11.85 |
ng/ml/h |
0.69 |
2.08 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50394 |
481 |
GH/OmrMcwi |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
renin activity |
male |
87 days-120 days |
8 |
|
|
11.16 |
ng/ml/h |
0.5 |
1.41 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50397 |
481 |
WKY/NCrl |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
urine sodium amount |
female |
87 days-120 days |
8 |
|
|
1.16 |
mEq/d |
0.2 |
0.56 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
50439 |
481 |
BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
21 |
|
serial mean |
111.8 |
mmHg |
3.9 |
17.87 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
0 |
|
|
|
|
69527 |
151 |
SS/JrHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then angiotensin II (100 ng/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
13 |
|
serial mean |
147.2 |
mmHg |
3.9 |
14.06 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
0 |
|
|
|
|
69532 |
151 |
BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then angiotensin II (200 ng/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
21 |
|
serial mean |
139.1 |
mmHg |
3.6 |
16.5 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
0 |
|
|
|
|
69533 |
151 |
SS/JrHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then acetylcholine (0.1 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
9 |
|
serial mean |
132.0 |
mmHg |
7.0 |
21.0 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
0 |
|
|
|
|
69542 |
151 |
BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then NG-nitroarginine methyl ester (5 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
21 |
|
serial mean |
137.4 |
mmHg |
4.0 |
18.33 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
0 |
|
|
|
|
69545 |
151 |
SS/JrHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then NG-nitroarginine methyl ester (5 mg/kg) then acetylcholine (0.1 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
9 |
|
serial mean |
160.0 |
mmHg |
6.7 |
20.1 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
0 |
|
|
|
|
69548 |
151 |
BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then NG-nitroarginine methyl ester (5 mg/kg) then acetylcholine (0.2 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
17 |
|
serial mean |
144.9 |
mmHg |
3.1 |
12.78 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
0 |
|
|
|
|
69549 |
151 |
BN/NHsdMcwi |
white blood cell count |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
leukocyte quantity |
female |
92 days-94 days |
13 |
|
|
0.02 |
x 1000 cells/ul |
1306.0 |
4708.85 |
isolated cell counting method |
|
0.0 |
|
0 |
|
|
|
|
69495 |
151 |
SS/JrHsdMcwi |
plasma high density lipoprotein cholesterol level |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
blood HDL cholesterol amount |
female |
92 days-94 days |
12 |
|
|
68.1 |
mg/dl |
4.5 |
15.59 |
plasma high-density lipoprotein-cholesterol measurement test |
|
0.0 |
|
0 |
|
|
|
|
69504 |
151 |
BN/NHsdMcwi |
urine potassium level |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
urine potassium amount |
female |
92 days-94 days |
22 |
|
|
93.4 |
mmol/l |
5.7 |
26.74 |
unspecified method |
|
0.0 |
|
0 |
|
urine potassium analysis |
|
|
69471 |
151 |
WKY |
body weight |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
body mass |
male |
266 days-280 days |
16 |
|
|
599.0 |
g |
35.0 |
140.0 |
body weighing method |
|
0.0 |
lad occlusion |
210 |
days |
|
|
|
100274 |
2460 |
WKY |
heart weight |
left anterior descending coronary artery occlusion (for 196 days) then furosemide (10 ml/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart mass |
male |
238 days-252 days |
20 |
|
|
1.56 |
g |
0.42 |
1.86 |
post excision weight measurement |
|
0.0 |
lad occlusion |
196 |
days |
|
|
|
100277 |
2460 |
WKY |
heart left ventricle end-systolic diameter |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-systolic diameter |
male |
266 days-280 days |
16 |
|
|
9.1 |
mm |
0.4 |
1.6 |
echocardiography |
|
0.0 |
lad occlusion |
210 |
days |
|
|
|
100310 |
2460 |
WKY |
left ventricular end-diastolic blood pressure |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ramipril (1 mg/kg/d) (for 182 days) then ketamine (80 mg/kg) then xylazine (10 mg/kg) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricular blood pressure trait |
male |
266 days-280 days |
32 |
10 min mean |
continuous mean |
5.96 |
mmHg |
0.84 |
4.75 |
vascular transducer tipped catheter |
|
0.0 |
lad occlusion |
210 |
days |
|
|
|
100326 |
2460 |
WKY |
E/A wave ratio |
left anterior descending coronary artery occlusion (for 196 days) then furosemide (10 ml/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
blood flow trait |
male |
238 days-252 days |
20 |
|
|
1.61 |
null |
0.21 |
0.94 |
echocardiography |
|
0.0 |
lad occlusion |
196 |
days |
|
|
|
100355 |
2460 |
SS-Chr 9BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
13 |
|
|
-9.41 |
mmHg |
2.27 |
8.17 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50805 |
481 |
SS-Chr 9BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
14 |
|
|
-8.84 |
mmHg |
1.27 |
4.74 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50808 |
481 |
BN/NHsdMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
4 |
|
|
-9.46 |
mmHg |
3.26 |
6.51 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50813 |
481 |
Hsd:SD |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
renin activity |
female |
87 days-120 days |
12 |
|
|
8.82 |
ng/ml/h |
1.04 |
3.62 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
50896 |
481 |
SS-Chr 16BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
5 |
|
|
21.19 |
beats/min |
4.88 |
10.9 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50907 |
481 |
SS/JrHsdMcwi |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
urine sodium amount |
male |
87 days-120 days |
6 |
|
|
1.39 |
mEq/d |
0.12 |
0.29 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51045 |
481 |
FHH/EurMcwi |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
urine sodium amount |
male |
87 days-120 days |
8 |
|
|
0.89 |
mEq/d |
0.23 |
0.64 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51050 |
481 |
GH/OmrMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
3 |
|
|
-15.69 |
mmHg |
7.96 |
13.79 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50629 |
481 |
Hsd:SD |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
urine sodium amount |
female |
87 days-120 days |
16 |
|
|
0.74 |
mEq/d |
0.11 |
0.43 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
51399 |
481 |
SS-Chr 18BN/Mcwi |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
male |
87 days-120 days |
4 |
|
|
1.66 |
ml/min |
0.1 |
0.2 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51447 |
481 |
SS-Chr 16BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
male |
87 days-120 days |
6 |
|
|
0.3 |
mg/dl |
0.06 |
0.15 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51538 |
481 |
SS-Chr 16BN/Mcwi |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
female |
87 days-120 days |
5 |
|
|
1.27 |
ml/min |
0.09 |
0.19 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51543 |
481 |
Crl:CD(SD) |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
6 |
|
|
-3.09 |
mmHg |
3.77 |
9.23 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51065 |
481 |
FHH/EurMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
7 |
|
|
2.47 |
beats/min |
9.71 |
25.69 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51087 |
481 |
F344/DuCrl |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
renin activity |
male |
87 days-120 days |
7 |
|
|
15.17 |
ng/ml/h |
1.06 |
2.81 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
50414 |
481 |
F344/DuCrl |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
renin activity |
female |
87 days-120 days |
8 |
|
|
10.84 |
ng/ml/h |
1.35 |
3.83 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
50416 |
481 |
LEW/Crl |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
urine sodium amount |
male |
87 days-120 days |
9 |
|
|
1.5 |
mEq/d |
0.11 |
0.34 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
50438 |
481 |
SS-Chr 16BN/Mcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
10 |
|
|
386.76 |
beats/min |
11.54 |
36.49 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51248 |
481 |
GH/OmrMcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
8 |
|
|
375.94 |
beats/min |
11.06 |
31.28 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51251 |
481 |
GH/OmrMcwi |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
urine sodium amount |
female |
87 days-120 days |
3 |
|
|
1.36 |
mEq/d |
0.12 |
0.21 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51268 |
481 |
F344/DuCrl |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
9 |
|
|
109.83 |
mmHg |
2.62 |
7.87 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51734 |
481 |
SHR/NCrl |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
8 |
|
|
127.98 |
mmHg |
2.2 |
6.22 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51825 |
481 |
SS/JrHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
10 |
|
|
130.93 |
mmHg |
4.07 |
12.88 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51826 |
481 |
FHH/EurMcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
10 |
|
|
121.77 |
mmHg |
0.93 |
2.94 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51829 |
481 |
BN/NHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
3 |
|
|
97.79 |
mmHg |
9.11 |
15.78 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51831 |
481 |
LEW/Crl |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
5 |
|
|
-10.73 |
mmHg |
2.75 |
6.14 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
|
51915 |
481 |
SS/JrHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
92 days-94 days |
12 |
|
serial mean |
142.0 |
mmHg |
5.0 |
17.32 |
vascular indwelling catheter method |
left femoral artery |
0 |
|
0 |
|
|
|
|
65467 |
151 |
SS/JrHsdMcwi |
heart rate |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
heart pumping trait |
female |
93 days
| 12 |
|
serial mean |
427.0 |
beats/min |
6.0 |
20.78 |
vascular indwelling catheter method |
left femoral artery |
0 |
|
0 |
|
|
|
|
65469 |
151 |
SS/JrHsdMcwi |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
male |
87 days-120 days |
4 |
|
|
1.51 |
ml/min |
0.23 |
0.45 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51448 |
481 |
SS/JrHsdMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
15 |
|
|
3.44 |
beats/min |
4.53 |
17.54 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50977 |
481 |
Hsd:SD |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
12 |
|
|
-0.36 |
mmHg |
1.59 |
5.52 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
51000 |
481 |
Hsd:SD |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
14 |
|
|
-2.46 |
mmHg |
2.3 |
8.59 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
51001 |
481 |
GH/OmrMcwi |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
renin activity |
male |
87 days-120 days |
7 |
|
|
4.42 |
ng/ml/h |
0.57 |
1.51 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51009 |
481 |
FHH/EurMcwi |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
renin activity |
male |
87 days-120 days |
4 |
|
|
7.2 |
ng/ml/h |
1.34 |
2.68 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51013 |
481 |
SS/JrHsdMcwi |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
male |
87 days-120 days |
12 |
|
|
1.26 |
ml/min |
0.24 |
0.84 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51052 |
481 |
GH/OmrMcwi |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
male |
87 days-120 days |
8 |
|
|
1.29 |
ml/min |
0.23 |
0.66 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51058 |
481 |
FHH/EurMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
7 |
|
|
-7.12 |
mmHg |
7.1 |
18.77 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50763 |
481 |
FHH/EurMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
6 |
|
|
3.0 |
mmHg |
6.88 |
16.84 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50767 |
481 |
SS/JrHsdMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
15 |
|
|
-12.57 |
mmHg |
1.76 |
6.83 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50801 |
481 |
SS-Chr 16BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
female |
87 days-120 days |
5 |
|
|
0.37 |
mg/dl |
0.02 |
0.05 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51174 |
481 |
FHH/EurMcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
male |
87 days-120 days |
9 |
|
|
0.29 |
mg/dl |
0.01 |
0.02 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51178 |
481 |
SS/JrHsdMcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
female |
87 days-120 days |
8 |
|
|
0.33 |
mg/dl |
0.01 |
0.02 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51180 |
481 |
BN/NHsdMcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
3 |
|
|
388.81 |
beats/min |
6.13 |
10.62 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51255 |
481 |
BN/NHsdMcwi |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
female |
87 days-120 days |
3 |
|
|
0.8 |
ml/min |
0.26 |
0.45 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51064 |
481 |
SHR/NCrl |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
8 |
|
|
-6.87 |
beats/min |
2.38 |
6.72 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51092 |
481 |
BN/NHsdMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
1 |
|
|
68.68 |
beats/min |
|
|
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51097 |
481 |
GH/OmrMcwi |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
urine sodium amount |
male |
87 days-120 days |
8 |
|
|
1.3 |
mEq/d |
0.09 |
0.26 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51522 |
481 |
SS-Chr 9BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
urine sodium amount |
female |
87 days-120 days |
16 |
|
|
1.32 |
mEq/d |
0.12 |
0.49 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51523 |
481 |
SS-Chr 16BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
female |
87 days-120 days |
5 |
|
|
0.35 |
mg/dl |
0.01 |
0.03 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51536 |
481 |
SS-Chr 18BN/Mcwi |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
male |
87 days-120 days |
6 |
|
|
1.92 |
ml/min |
0.12 |
0.28 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51540 |
481 |
SHR/NCrl |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
female |
87 days-120 days |
7 |
|
|
1.08 |
ml/min |
0.08 |
0.2 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51544 |
481 |
GH/OmrMcwi |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
female |
87 days-120 days |
3 |
|
|
1.69 |
ml/min |
0.06 |
0.1 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51545 |
481 |
SHR/NCrl |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
male |
87 days-120 days |
5 |
|
|
1.42 |
ml/min |
0.18 |
0.41 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51550 |
481 |
SS-Chr 20BN/Mcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
13 |
|
|
440.55 |
beats/min |
8.86 |
31.96 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50879 |
481 |
F344/DuCrl |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
male |
87 days-120 days |
5 |
|
|
1.04 |
ml/min |
0.2 |
0.44 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51257 |
481 |
SS/JrHsdMcwi |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
urine sodium amount |
female |
87 days-120 days |
11 |
|
|
0.78 |
mEq/d |
0.1 |
0.33 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51271 |
481 |
Hsd:SD |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
female |
87 days-120 days |
13 |
|
|
0.34 |
mg/dl |
0.01 |
0.04 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
51278 |
481 |
BN/NHsdMcwi |
plasma triglyceride level |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
blood triglyceride amount |
female |
92 days-94 days |
7 |
|
|
0.72 |
mmol/l |
0.11 |
0.3 |
plasma triglyceride analysis |
|
0.0 |
|
0 |
|
|
|
|
67291 |
151 |
WKY/NCrl |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
6 |
|
|
18.29 |
beats/min |
7.47 |
18.3 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
|
52067 |
481 |
Crl:CD(SD) |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
male |
87 days-120 days |
6 |
|
|
0.32 |
mg/dl |
0.02 |
0.05 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51984 |
481 |
F344/DuCrl |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
male |
87 days-120 days |
5 |
|
|
0.29 |
mg/dl |
0.02 |
0.05 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51985 |
481 |
SS-Chr 16BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
renin activity |
female |
87 days-120 days |
5 |
|
|
3.3 |
ng/ml/h |
0.43 |
0.97 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50568 |
481 |
FHH/EurMcwi |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
renin activity |
male |
87 days-120 days |
4 |
|
|
12.93 |
ng/ml/h |
1.15 |
2.3 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50571 |
481 |
SS-Chr 16BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
6 |
|
|
-4.07 |
mmHg |
2.8 |
6.86 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50628 |
481 |
SS-Chr 16BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
10 |
|
|
-13.4 |
mmHg |
2.93 |
9.26 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50630 |
481 |
SS/JrHsdMcwi |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
renin activity |
male |
87 days-120 days |
15 |
|
|
2.88 |
ng/ml/h |
0.5 |
1.95 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50388 |
481 |
SS/JrHsdMcwi |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
renin activity |
female |
87 days-120 days |
9 |
|
|
3.86 |
ng/ml/h |
0.51 |
1.54 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50395 |
481 |
SS/JrHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then norepinephrine (0.5 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
13 |
|
serial mean |
141.7 |
mmHg |
7.4 |
26.68 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
0 |
|
|
|
|
69536 |
151 |
SS/JrHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then norepinephrine (1 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
13 |
|
serial mean |
159.0 |
mmHg |
6.4 |
23.08 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
0 |
|
|
|
|
69538 |
151 |
BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then acetylcholine (0.2 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
16 |
|
serial mean |
118.6 |
mmHg |
3.4 |
13.6 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
0 |
|
|
|
|
69543 |
151 |
SS/JrHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then acetylcholine (0.2 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
9 |
|
serial mean |
134.7 |
mmHg |
7.4 |
22.2 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
0 |
|
|
|
|
69544 |
151 |
SS/JrHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then NG-nitroarginine methyl ester (5 mg/kg) then acetylcholine (0.2 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
9 |
|
serial mean |
159.1 |
mmHg |
6.4 |
19.2 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
0 |
|
|
|
|
69550 |
151 |
SS/JrHsdMcwi |
plasma creatinine level |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
blood creatinine amount |
female |
92 days-94 days |
11 |
|
|
1.05 |
mg/dl |
0.23 |
0.76 |
plasma creatinine analysis |
|
0.0 |
|
0 |
|
urine potassium analysis |
umol/min |
|
69486 |
151 |
WKY |
heart weight to tibia length ratio |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart mass |
male |
266 days-280 days |
16 |
|
|
0.4 |
g/cm |
0.1 |
0.4 |
post excision weight measurement |
|
0.0 |
lad occlusion |
210 |
days |
|
|
|
100283 |
2460 |
WKY |
tibia length |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ramipril (1 mg/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
tibia length |
male |
266 days-280 days |
32 |
|
|
4.3 |
cm |
0.09 |
0.51 |
post excision length measurement |
|
0.0 |
lad occlusion |
210 |
days |
|
|
|
100287 |
2460 |
WKY |
ejection fraction |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ramipril (1 mg/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
cardiac output trait |
male |
266 days-280 days |
32 |
|
|
40.5 |
% |
2.4 |
13.58 |
echocardiography |
|
0.0 |
lad occlusion |
210 |
days |
|
|
|
100302 |
2460 |
WKY |
artery tunica media width to artery inner diameter ratio |
left anterior descending coronary artery occlusion (for 196 days) then furosemide (10 ml/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
kidney blood vessel morphology trait |
male |
238 days-252 days |
15 |
|
|
1.56 |
null |
0.1 |
0.39 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
lad occlusion |
196 |
days |
|
|
|
100387 |
2460 |
WKY |
diastolic blood pressure |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ketamine (80 mg/kg) then xylazine (10 mg/kg) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
arterial blood pressure trait |
male |
266 days-280 days |
16 |
10 min mean |
continuous mean |
53.0 |
mmHg |
5.2 |
20.8 |
vascular transducer tipped catheter |
|
0.0 |
lad occlusion |
210 |
days |
|
|
|
100319 |
2460 |
WKY |
left ventricular end-diastolic blood pressure |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ketamine (80 mg/kg) then xylazine (10 mg/kg) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricular blood pressure trait |
male |
266 days-280 days |
16 |
10 min mean |
continuous mean |
9.36 |
mmHg |
1.62 |
6.48 |
vascular transducer tipped catheter |
|
0.0 |
lad occlusion |
210 |
days |
|
|
|
100325 |
2460 |
WKY |
serum sodium level |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
blood sodium amount |
male |
266 days-280 days |
16 |
|
|
153.5 |
mmol/l |
2.1 |
8.4 |
automated serum sodium test |
|
0.0 |
lad occlusion |
210 |
days |
|
|
|
100331 |
2460 |
WKY |
heart left ventricle end-diastolic diameter |
left anterior descending coronary artery occlusion (for 196 days) then furosemide (10 ml/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-diastolic diameter |
male |
238 days-252 days |
20 |
|
|
10.6 |
mm |
0.2 |
0.89 |
echocardiography |
|
0.0 |
lad occlusion |
196 |
days |
|
|
|
100340 |
2460 |
WKY/NCrl |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
6 |
|
|
113.96 |
mmHg |
3.81 |
9.34 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
|
50839 |
481 |
SS/JrHsdMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
18 |
|
|
-22.81 |
mmHg |
3.9 |
16.57 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50627 |
481 |
SS-Chr 20BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
13 |
|
|
-11.14 |
mmHg |
2.22 |
8.02 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50802 |
481 |
SS-Chr 16BN/Mcwi |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
female |
87 days-120 days |
4 |
|
|
1.14 |
ml/min |
0.06 |
0.13 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51450 |
481 |
GH/OmrMcwi |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
urine sodium amount |
female |
87 days-120 days |
10 |
|
|
1.06 |
mEq/d |
0.11 |
0.35 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51518 |
481 |
SS/JrHsdMcwi |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
male |
87 days-120 days |
15 |
|
|
1.61 |
ml/min |
0.19 |
0.75 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51541 |
481 |
SS/JrHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (for 28 days) then controlled sodium content diet (8 %) (for 31 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 1.5 days) then controlled exposure to ambient light (for 12 hours) |
Cowley AW Jr, et al., Physiol Genomics 2000 Apr 27;2(3):107-15. |
arterial blood pressure trait |
male |
96 days
| 24 |
|
continuous mean |
141.0 |
mmHg |
5.0 |
24.49 |
vascular indwelling catheter method |
femoral artery |
10800.0 |
|
0 |
|
left femoral artery |
|
|
12038 |
229 |
F344/DuCrl |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
9 |
|
|
-5.94 |
mmHg |
2.7 |
8.1 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51068 |
481 |
SS/JrHsdMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
10 |
|
|
5.72 |
beats/min |
7.43 |
23.5 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51093 |
481 |
FHH/EurMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
10 |
|
|
17.17 |
beats/min |
7.37 |
23.3 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51096 |
481 |
SHR/NCrl |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
renin activity |
male |
87 days-120 days |
8 |
|
|
9.13 |
ng/ml/h |
0.66 |
1.87 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50396 |
481 |
WKY/NCrl |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
urine sodium amount |
male |
87 days-120 days |
9 |
|
|
1.07 |
mEq/d |
0.08 |
0.24 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
50436 |
481 |
SS-Chr 18BN/Mcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
7 |
|
|
383.32 |
beats/min |
7.64 |
20.22 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51243 |
481 |
BN/NHsdMcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
1 |
|
|
432.84 |
beats/min |
|
|
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51254 |
481 |
BN/NHsdMcwi |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
urine sodium amount |
female |
87 days-120 days |
9 |
|
|
1.23 |
mEq/d |
0.15 |
0.45 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51276 |
481 |
SS/JrHsdMcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
male |
87 days-120 days |
12 |
|
|
0.31 |
mg/dl |
0.01 |
0.04 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51310 |
481 |
SS/JrHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
15 |
|
|
131.99 |
mmHg |
3.79 |
14.69 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51997 |
481 |
LEW/Crl |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
female |
87 days-120 days |
5 |
|
|
1.64 |
ml/min |
0.16 |
0.36 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
|
52028 |
481 |
WKY |
heart left ventricle infarction size to total heart left ventricle size ratio |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle integrity trait |
male |
266 days-280 days |
16 |
|
|
31.8 |
% |
10.1 |
40.4 |
ex vivo microscopy with digital image analysis |
|
0.0 |
lad occlusion |
210 |
days |
|
|
|
100265 |
2460 |
WKY |
lung wet weight |
left anterior descending coronary artery occlusion (for 196 days) then furosemide (10 ml/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
lung mass |
male |
238 days-252 days |
20 |
|
|
2.24 |
g |
0.19 |
0.85 |
post excision weight measurement |
|
0.0 |
lad occlusion |
196 |
days |
|
|
|
100298 |
2460 |
WKY |
timed urine volume |
left anterior descending coronary artery occlusion (for 196 days) then furosemide (10 ml/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
urine output |
male |
238 days-252 days |
7 |
|
|
11.4 |
ml/d |
2.4 |
6.35 |
urine volume measurement method |
|
0.0 |
lad occlusion |
196 |
days |
|
|
|
100375 |
2460 |
BN/NHsdMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) then tactile electric shock exposure (2 %) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
92 days-94 days |
14 |
|
serial mean |
16.0 |
mmHg |
3.0 |
11.22 |
vascular indwelling catheter method |
left femoral artery |
0 |
|
0 |
|
|
|
|
66149 |
151 |
LEW/Crl |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
4 |
|
|
-23.46 |
beats/min |
11.46 |
22.92 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
|
52066 |
481 |
SS/JrHsdMcwi |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
renin activity |
male |
87 days-120 days |
2 |
|
|
1.95 |
ng/ml/h |
0.95 |
1.34 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50566 |
481 |
SS-Chr 16BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
renin activity |
male |
87 days-120 days |
6 |
|
|
2.26 |
ng/ml/h |
0.6 |
1.47 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50570 |
481 |
Crl:CD(SD) |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
6 |
|
|
402.53 |
beats/min |
6.39 |
15.65 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
50576 |
481 |
Crl:CD(SD) |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
5 |
|
|
425.43 |
beats/min |
14.64 |
32.74 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
50578 |
481 |
SHR/NCrl |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
8 |
|
|
-25.11 |
mmHg |
3.07 |
8.68 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50631 |
481 |
F344/DuCrl |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
female |
87 days-120 days |
8 |
|
|
0.25 |
mg/dl |
0.01 |
0.02 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51987 |
481 |
FHH/EurMcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
5 |
|
|
130.75 |
mmHg |
7.93 |
17.73 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51996 |
481 |
SHR/NCrl |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
6 |
|
|
156.06 |
mmHg |
6.95 |
17.02 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
52002 |
481 |
SS-Chr 9BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
14 |
|
|
123.13 |
mmHg |
1.84 |
6.88 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
52004 |
481 |
WKY/NCrl |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
male |
87 days-120 days |
9 |
|
|
1.5 |
ml/min |
0.15 |
0.45 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
|
52027 |
481 |
WKY/NCrl |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
female |
87 days-120 days |
5 |
|
|
0.94 |
ml/min |
0.17 |
0.39 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
|
52030 |
481 |
Hsd:SD |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
14 |
|
|
108.56 |
mmHg |
1.93 |
7.23 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
51789 |
481 |
GH/OmrMcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
3 |
|
|
140.54 |
mmHg |
14.06 |
24.36 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51823 |
481 |
SS-Chr 16BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
10 |
|
|
123.09 |
mmHg |
2.44 |
7.73 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51824 |
481 |
BN/NHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
1 |
|
|
112.16 |
mmHg |
|
|
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51830 |
481 |
LEW/Crl |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
4 |
|
|
-4.69 |
mmHg |
2.7 |
5.4 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
|
51916 |
481 |
BN/NHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
92 days-94 days |
14 |
|
serial mean |
89.0 |
mmHg |
2.0 |
7.48 |
vascular indwelling catheter method |
left femoral artery |
0 |
|
0 |
|
|
|
|
65466 |
151 |
BN/NHsdMcwi |
heart rate |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
heart pumping trait |
female |
93 days
| 14 |
|
serial mean |
395.0 |
beats/min |
7.0 |
26.19 |
vascular indwelling catheter method |
left femoral artery |
0 |
|
0 |
|
|
|
|
65468 |
151 |
SS-Chr 20BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
13 |
|
|
25.74 |
beats/min |
10.93 |
39.41 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50978 |
481 |
GH/OmrMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
9 |
|
|
4.64 |
beats/min |
5.39 |
16.16 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50979 |
481 |
SHR/NCrl |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
6 |
|
|
12.15 |
beats/min |
5.65 |
13.83 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50982 |
481 |
SS-Chr 9BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
14 |
|
|
10.17 |
beats/min |
8.23 |
30.81 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50984 |
481 |
SS/JrHsdMcwi |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
renin activity |
male |
87 days-120 days |
12 |
|
|
1.15 |
ng/ml/h |
0.27 |
0.94 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51003 |
481 |
SS-Chr 9BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
renin activity |
male |
87 days-120 days |
11 |
|
|
0.91 |
ng/ml/h |
0.18 |
0.59 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51007 |
481 |
SS-Chr 9BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
renin activity |
female |
87 days-120 days |
14 |
|
|
2.21 |
ng/ml/h |
0.35 |
1.3 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51010 |
481 |
SHR/NCrl |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
male |
87 days-120 days |
5 |
|
|
0.83 |
ml/min |
0.17 |
0.38 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51057 |
481 |
SS-Chr 20BN/Mcwi |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
male |
87 days-120 days |
10 |
|
|
1.2 |
ml/min |
0.12 |
0.38 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51061 |
481 |
Crl:CD(SD) |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
female |
87 days-120 days |
3 |
|
|
1.5 |
ml/min |
0.2 |
0.34 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51258 |
481 |
FHH/EurMcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
female |
87 days-120 days |
5 |
|
|
0.25 |
mg/dl |
0.01 |
0.03 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51309 |
481 |
GH/OmrMcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
female |
87 days-120 days |
10 |
|
|
0.36 |
mg/dl |
0.02 |
0.06 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51312 |
481 |
SS-Chr 9BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
male |
87 days-120 days |
12 |
|
|
0.3 |
mg/dl |
0.01 |
0.04 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51314 |
481 |
GH/OmrMcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
male |
87 days-120 days |
8 |
|
|
0.31 |
mg/dl |
0.02 |
0.06 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51316 |
481 |
FHH/EurMcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
male |
87 days-120 days |
4 |
|
|
0.25 |
mg/dl |
0.01 |
0.02 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51320 |
481 |
BN/NHsdMcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
female |
87 days-120 days |
3 |
|
|
0.3 |
mg/dl |
0.02 |
0.04 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51322 |
481 |
Crl:CD(SD) |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
urine sodium amount |
female |
87 days-120 days |
9 |
|
|
1.68 |
mEq/d |
0.25 |
0.74 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51364 |
481 |
SS/JrHsdMcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
5 |
|
|
393.13 |
beats/min |
12.55 |
28.06 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51380 |
481 |
FHH/EurMcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
7 |
|
|
432.9 |
beats/min |
8.18 |
21.65 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51381 |
481 |
SS-Chr 18BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
7 |
|
|
3.43 |
beats/min |
11.16 |
29.52 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51086 |
481 |
SS-Chr 16BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
6 |
|
|
-4.01 |
beats/min |
12.94 |
31.69 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51089 |
481 |
SHR/NCrl |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
7 |
|
|
-2.86 |
beats/min |
5.12 |
13.54 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51095 |
481 |
SS-Chr 18BN/Mcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
3 |
|
|
465.42 |
beats/min |
20.72 |
35.89 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51383 |
481 |
SS-Chr 16BN/Mcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
7 |
|
|
368.95 |
beats/min |
11.17 |
29.55 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51384 |
481 |
FHH/EurMcwi |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
female |
87 days-120 days |
6 |
|
|
1.5 |
ml/min |
0.12 |
0.3 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51449 |
481 |
SS-Chr 9BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
urine sodium amount |
male |
87 days-120 days |
16 |
|
|
1.23 |
mEq/d |
0.16 |
0.63 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51520 |
481 |
FHH/EurMcwi |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
urine sodium amount |
male |
87 days-120 days |
5 |
|
|
0.8 |
mEq/d |
0.21 |
0.46 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51526 |
481 |
SS-Chr 18BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
male |
87 days-120 days |
5 |
|
|
0.28 |
mg/dl |
0.06 |
0.14 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51533 |
481 |
SS/JrHsdMcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
male |
87 days-120 days |
4 |
|
|
0.35 |
mg/dl |
0.02 |
0.03 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51534 |
481 |
SS-Chr 18BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
5 |
|
|
-3.43 |
mmHg |
1.25 |
2.78 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50804 |
481 |
GH/OmrMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
8 |
|
|
-6.61 |
mmHg |
7.53 |
21.31 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50807 |
481 |
SHR/NCrl |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
6 |
|
|
-15.3 |
mmHg |
6.88 |
16.84 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50809 |
481 |
SS/JrHsdMcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
15 |
|
|
386.98 |
beats/min |
5.77 |
22.33 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50878 |
481 |
SHR/NCrl |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
6 |
|
|
357.13 |
beats/min |
8.47 |
20.75 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50883 |
481 |
GH/OmrMcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
8 |
|
|
393.96 |
beats/min |
5.0 |
14.15 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50884 |
481 |
Hsd:SD |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
renin activity |
male |
87 days-120 days |
8 |
|
|
6.46 |
ng/ml/h |
0.58 |
1.64 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
50895 |
481 |
SS-Chr 18BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
5 |
|
|
10.88 |
beats/min |
6.24 |
13.95 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50904 |
481 |
FHH/EurMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
7 |
|
|
12.14 |
beats/min |
6.37 |
16.86 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50906 |
481 |
SS/JrHsdMcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
male |
87 days-120 days |
15 |
|
|
0.39 |
mg/dl |
0.06 |
0.21 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51172 |
481 |
FHH/EurMcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
female |
87 days-120 days |
7 |
|
|
0.28 |
mg/dl |
0.01 |
0.03 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51173 |
481 |
SHR/NCrl |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
7 |
|
|
355.95 |
beats/min |
5.94 |
15.72 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51252 |
481 |
SS/JrHsdMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
5 |
|
|
-8.98 |
mmHg |
4.38 |
9.8 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50762 |
481 |
SS-Chr 16BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
7 |
|
|
-11.26 |
mmHg |
2.11 |
5.58 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50766 |
481 |
SHR/NCrl |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
renin activity |
female |
87 days-120 days |
7 |
|
|
10.95 |
ng/ml/h |
1.24 |
3.28 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50391 |
481 |
GH/OmrMcwi |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
renin activity |
female |
87 days-120 days |
3 |
|
|
7.09 |
ng/ml/h |
3.05 |
5.29 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50392 |
481 |
LEW/Crl |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
female |
87 days-120 days |
5 |
|
|
0.32 |
mg/dl |
0.02 |
0.05 |
radioimmunoassay |
|
|
|
0 |
|
|
|
|
50410 |
481 |
Crl:CD(SD) |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
renin activity |
female |
87 days-120 days |
2 |
|
|
5.07 |
ng/ml/h |
0.24 |
0.33 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
50415 |
481 |
SS/JrHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
13 |
|
serial mean |
126.0 |
mmHg |
4.1 |
14.78 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
0 |
|
|
|
|
69528 |
151 |
SS/JrHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then angiotensin II (200 ng/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
13 |
|
serial mean |
160.2 |
mmHg |
3.5 |
12.62 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
0 |
|
|
|
|
69534 |
151 |
BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then norepinephrine (0.5 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
21 |
|
serial mean |
120.4 |
mmHg |
5.3 |
24.29 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
0 |
|
|
|
|
69535 |
151 |
SS/JrHsdMcwi |
urine creatinine excretion rate |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
urine creatinine amount |
female |
92 days-94 days |
16 |
|
|
0.0 |
mg/d |
0.0 |
0.0 |
urine creatinine analysis |
|
0.0 |
|
0 |
|
|
mg/min |
|
69478 |
151 |
BN/NHsdMcwi |
creatinine clearance |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
glomerular filtration trait |
female |
92 days-94 days |
8 |
|
|
1.1 |
ml/min |
0.2 |
0.57 |
urine creatinine analysis |
|
0.0 |
|
0 |
|
|
mg/min |
|
69479 |
151 |
WKY |
heart left ventricle infarction size to total heart left ventricle size ratio |
left anterior descending coronary artery occlusion (for 196 days) then furosemide (10 ml/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle integrity trait |
male |
238 days-252 days |
20 |
|
|
35.2 |
% |
4.5 |
20.12 |
ex vivo microscopy with digital image analysis |
|
0.0 |
lad occlusion |
196 |
days |
|
|
|
100263 |
2460 |
WKY |
heart weight |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart mass |
male |
266 days-280 days |
16 |
|
|
1.88 |
g |
0.61 |
2.42 |
post excision weight measurement |
|
0.0 |
lad occlusion |
210 |
days |
|
|
|
100280 |
2460 |
WKY |
heart left ventricle weight |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ramipril (1 mg/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle mass |
male |
266 days-280 days |
32 |
|
|
0.93 |
g |
0.1 |
0.54 |
post excision weight measurement |
|
0.0 |
lad occlusion |
210 |
days |
|
|
|
100293 |
2460 |
WKY |
right kidney wet weight |
left anterior descending coronary artery occlusion (for 196 days) then furosemide (10 ml/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
kidney mass |
male |
238 days-252 days |
15 |
|
|
1.37 |
g |
0.04 |
0.14 |
post excision weight measurement |
|
0.0 |
lad occlusion |
196 |
days |
|
|
|
100372 |
2460 |
WKY |
kidney fibrotic lesion area to total kidney area ratio |
left anterior descending coronary artery occlusion (for 196 days) then furosemide (10 ml/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
kidney integrity trait |
male |
238 days-252 days |
15 |
|
|
0.48 |
% |
0.11 |
0.43 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
lad occlusion |
196 |
days |
|
|
|
100384 |
2460 |
WKY |
systolic blood pressure |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ketamine (80 mg/kg) then xylazine (10 mg/kg) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
arterial blood pressure trait |
male |
266 days-280 days |
16 |
10 min mean |
continuous mean |
79.5 |
mmHg |
5.1 |
20.4 |
vascular transducer tipped catheter |
|
0.0 |
lad occlusion |
210 |
days |
|
|
|
100316 |
2460 |
WKY |
systolic blood pressure |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ramipril (1 mg/kg/d) (for 182 days) then ketamine (80 mg/kg) then xylazine (10 mg/kg) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
arterial blood pressure trait |
male |
266 days-280 days |
32 |
10 min mean |
continuous mean |
75.1 |
mmHg |
2.4 |
13.58 |
vascular transducer tipped catheter |
|
0.0 |
lad occlusion |
210 |
days |
|
|
|
100317 |
2460 |
WKY |
diastolic blood pressure |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ramipril (1 mg/kg/d) (for 182 days) then ketamine (80 mg/kg) then xylazine (10 mg/kg) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
arterial blood pressure trait |
male |
266 days-280 days |
32 |
10 min mean |
continuous mean |
47.6 |
mmHg |
2.7 |
15.27 |
vascular transducer tipped catheter |
|
0.0 |
lad occlusion |
210 |
days |
|
|
|
100320 |
2460 |
WKY |
left ventricular end-systolic blood pressure |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ramipril (1 mg/kg/d) (for 182 days) then ketamine (80 mg/kg) then xylazine (10 mg/kg) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricular blood pressure trait |
male |
266 days-280 days |
32 |
10 min mean |
continuous mean |
67.5 |
mmHg |
3.9 |
22.06 |
vascular transducer tipped catheter |
|
0.0 |
lad occlusion |
210 |
days |
|
|
|
100323 |
2460 |
WKY |
maximum rate of positive change in left ventricular blood pressure |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ketamine (80 mg/kg) then xylazine (10 mg/kg) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricular blood pressure trait |
male |
266 days-280 days |
16 |
10 min mean |
continuous mean |
2912.0 |
mmHg/s |
300.0 |
1200.0 |
vascular transducer tipped catheter |
|
0.0 |
lad occlusion |
210 |
days |
|
|
|
100328 |
2460 |
WKY |
heart left ventricle end-systolic diameter |
left anterior descending coronary artery occlusion (for 196 days) then furosemide (10 ml/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-systolic diameter |
male |
238 days-252 days |
20 |
|
|
9.0 |
mm |
0.2 |
0.89 |
echocardiography |
|
0.0 |
lad occlusion |
196 |
days |
|
|
|
100343 |
2460 |
WKY |
heart left ventricle fractional shortening |
left anterior descending coronary artery occlusion (for 196 days) then furosemide (10 ml/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-diastolic diameter |
male |
238 days-252 days |
20 |
|
|
15.1 |
% |
1.0 |
4.47 |
echocardiography |
|
0.0 |
lad occlusion |
196 |
days |
|
|
|
100349 |
2460 |
WKY |
right kidney wet weight |
left anterior descending coronary artery occlusion (for 196 days) then furosemide (10 ml/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
kidney mass |
male |
238 days-252 days |
15 |
|
|
1.37 |
g |
0.04 |
0.14 |
post excision weight measurement |
|
0.0 |
lad occlusion |
196 |
days |
|
|
|
100358 |
2460 |
WKY |
timed urine volume |
left anterior descending coronary artery occlusion (for 196 days) then furosemide (10 ml/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
urine output |
male |
238 days-252 days |
7 |
|
|
11.4 |
ml/d |
2.4 |
6.35 |
urine volume measurement method |
|
0.0 |
lad occlusion |
196 |
days |
|
|
|
100361 |
2460 |
SS-Chr 18BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
urine sodium amount |
female |
87 days-120 days |
4 |
|
|
0.79 |
mEq/d |
0.09 |
0.17 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51048 |
481 |
SS-Chr 20BN/Mcwi |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
female |
87 days-120 days |
10 |
|
|
1.13 |
ml/min |
0.15 |
0.46 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51053 |
481 |
SS/JrHsdMcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
18 |
|
|
383.68 |
beats/min |
7.38 |
31.32 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51245 |
481 |
SHR/NCrl |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
urine sodium amount |
female |
87 days-120 days |
9 |
|
|
1.32 |
mEq/d |
0.09 |
0.28 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51273 |
481 |
SS-Chr 18BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
female |
87 days-120 days |
5 |
|
|
0.29 |
mg/dl |
0.01 |
0.02 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51313 |
481 |
SS-Chr 18BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
renin activity |
male |
87 days-120 days |
7 |
|
|
2.5 |
ng/ml/h |
0.55 |
1.46 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50387 |
481 |
SS-Chr 16BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
renin activity |
female |
87 days-120 days |
5 |
|
|
5.67 |
ng/ml/h |
1.28 |
2.87 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50390 |
481 |
LEW/Crl |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
male |
87 days-120 days |
4 |
|
|
0.32 |
mg/dl |
0.01 |
0.03 |
radioimmunoassay |
|
|
|
0 |
|
|
|
|
50411 |
481 |
SS/JrHsdMcwi |
plasma triglyceride level |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
blood triglyceride amount |
female |
92 days-94 days |
11 |
|
|
1.4 |
mmol/l |
0.21 |
0.71 |
plasma triglyceride analysis |
|
0.0 |
|
0 |
|
|
|
|
67292 |
151 |
BN/NHsdMcwi |
absolute change in mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then norepinephrine (3 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
19 |
|
serial mean |
22.0 |
mmHg |
3.0 |
13.08 |
vascular indwelling catheter method |
left femoral artery |
0.0 |
|
0 |
|
|
|
|
67301 |
151 |
WKY/NCrl |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
9 |
|
|
-14.79 |
mmHg |
5.52 |
16.56 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
|
51914 |
481 |
Crl:CD(SD) |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
female |
87 days-120 days |
3 |
|
|
0.33 |
mg/dl |
0.02 |
0.03 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51986 |
481 |
SS/JrHsdMcwi |
urine sodium excretion rate |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
urine sodium amount |
female |
92 days-94 days |
14 |
|
|
0.56 |
mEq/d |
0.06 |
0.21 |
unspecified method |
|
0.0 |
|
0 |
|
urine sodium analysis |
umol/min |
|
69469 |
151 |
BN/NHsdMcwi |
urine creatinine level |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
urine creatinine amount |
female |
92 days-94 days |
25 |
|
|
56.4 |
mg/dl |
4.95 |
24.75 |
urine creatinine analysis |
|
0.0 |
|
0 |
|
|
|
|
69475 |
151 |
BN/NHsdMcwi |
urine creatinine excretion rate |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
urine creatinine amount |
female |
92 days-94 days |
25 |
|
|
0.0 |
mg/d |
0.0 |
0.0 |
urine creatinine analysis |
|
0.0 |
|
0 |
|
|
mg/min |
|
69477 |
151 |
SS/JrHsdMcwi |
white blood cell count |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
leukocyte quantity |
female |
92 days-94 days |
9 |
|
|
0.01 |
x 1000 cells/ul |
1044.0 |
3132.0 |
isolated cell counting method |
|
0.0 |
|
0 |
|
|
|
|
69496 |
151 |
WKY |
heart weight to tibia length ratio |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ramipril (1 mg/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart mass |
male |
266 days-280 days |
32 |
|
|
0.31 |
g/cm |
0.04 |
0.23 |
post excision weight measurement |
|
0.0 |
lad occlusion |
210 |
days |
|
|
|
100284 |
2460 |
WKY |
heart left ventricle weight |
left anterior descending coronary artery occlusion (for 196 days) then furosemide (10 ml/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle mass |
male |
238 days-252 days |
20 |
|
|
0.96 |
g |
0.12 |
0.53 |
post excision weight measurement |
|
0.0 |
lad occlusion |
196 |
days |
|
|
|
100289 |
2460 |
WKY |
heart left ventricle weight to tibia length ratio |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle mass |
male |
266 days-280 days |
16 |
|
|
0.24 |
g/cm |
0.03 |
0.12 |
post excision weight measurement |
|
0.0 |
lad occlusion |
210 |
days |
|
lv/tl |
|
100295 |
2460 |
WKY |
heart left ventricle end-diastolic diameter |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ramipril (1 mg/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-diastolic diameter |
male |
266 days-280 days |
32 |
|
|
10.6 |
mm |
0.3 |
1.7 |
echocardiography |
|
0.0 |
lad occlusion |
210 |
days |
|
|
|
100308 |
2460 |
FHH/EurMcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
7 |
|
|
116.75 |
mmHg |
1.54 |
4.07 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51820 |
481 |
SS/JrHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
18 |
|
|
135.0 |
mmHg |
5.04 |
21.4 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51821 |
481 |
SHR/NCrl |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
7 |
|
|
117.77 |
mmHg |
2.86 |
7.56 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51828 |
481 |
Crl:CD(SD) |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
6 |
|
|
108.62 |
mmHg |
3.76 |
9.22 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51731 |
481 |
Crl:CD(SD) |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
5 |
|
|
101.2 |
mmHg |
3.26 |
7.28 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51733 |
481 |
SS/JrHsdMcwi |
plasma renin activity level |
controlled sodium content diet (0.4 %) (for 35 days) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
renin activity |
female |
95 days
| 7 |
|
|
4.7 |
ng/ml/h |
1.6 |
4.23 |
ex vivo blood analysis |
|
0 |
|
0 |
|
|
|
|
65473 |
151 |
SS-Chr 20BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
urine sodium amount |
female |
87 days-120 days |
18 |
|
|
1.0 |
mEq/d |
0.12 |
0.49 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51517 |
481 |
SS-Chr 20BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
urine sodium amount |
male |
87 days-120 days |
18 |
|
|
1.11 |
mEq/d |
0.13 |
0.54 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51525 |
481 |
BN/NHsdMcwi |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
urine sodium amount |
female |
87 days-120 days |
9 |
|
|
1.05 |
mEq/d |
0.12 |
0.36 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51528 |
481 |
FHH/EurMcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
male |
87 days-120 days |
4 |
|
|
0.28 |
mg/dl |
0.02 |
0.04 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51539 |
481 |
FHH/EurMcwi |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
male |
87 days-120 days |
9 |
|
|
2.23 |
ml/min |
0.08 |
0.25 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51547 |
481 |
Hsd:SD |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
urine sodium amount |
male |
87 days-120 days |
20 |
|
|
1.19 |
mEq/d |
0.1 |
0.46 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
51398 |
481 |
Hsd:SD |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
12 |
|
|
20.86 |
beats/min |
10.81 |
37.45 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
51400 |
481 |
SS-Chr 16BN/Mcwi |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
male |
87 days-120 days |
5 |
|
|
1.54 |
ml/min |
0.24 |
0.55 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51452 |
481 |
SS-Chr 16BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
male |
87 days-120 days |
7 |
|
|
0.35 |
mg/dl |
0.01 |
0.02 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51177 |
481 |
BN/NHsdMcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
female |
87 days-120 days |
2 |
|
|
0.26 |
mg/dl |
0.06 |
0.08 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51179 |
481 |
GH/OmrMcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
3 |
|
|
407.56 |
beats/min |
2.82 |
4.89 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51247 |
481 |
SS/JrHsdMcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
10 |
|
|
407.56 |
beats/min |
6.03 |
19.06 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51250 |
481 |
FHH/EurMcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
10 |
|
|
399.95 |
beats/min |
7.51 |
23.75 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51253 |
481 |
SHR/NCrl |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
6 |
|
|
-15.47 |
mmHg |
6.08 |
14.9 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50806 |
481 |
Hsd:SD |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
14 |
|
|
428.56 |
beats/min |
6.77 |
25.34 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
50815 |
481 |
SS-Chr 18BN/Mcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
5 |
|
|
409.57 |
beats/min |
5.76 |
12.88 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50881 |
481 |
SS-Chr 9BN/Mcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
13 |
|
|
395.28 |
beats/min |
9.37 |
33.79 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50882 |
481 |
SS-Chr 18BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
3 |
|
|
15.12 |
beats/min |
28.47 |
49.3 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50908 |
481 |
Crl:CD(SD) |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
6 |
|
|
18.95 |
beats/min |
7.34 |
17.98 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51260 |
481 |
SS-Chr 16BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
urine sodium amount |
male |
87 days-120 days |
10 |
|
|
1.62 |
mEq/d |
0.15 |
0.47 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51269 |
481 |
FHH/EurMcwi |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
urine sodium amount |
male |
87 days-120 days |
10 |
|
|
2.11 |
mEq/d |
0.17 |
0.54 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51274 |
481 |
SS-Chr 18BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
5 |
|
|
105.29 |
mmHg |
2.43 |
5.43 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51323 |
481 |
SS-Chr 18BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
3 |
|
|
107.87 |
mmHg |
1.27 |
2.21 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51327 |
481 |
Crl:CD(SD) |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
urine sodium amount |
male |
87 days-120 days |
9 |
|
|
1.82 |
mEq/d |
0.27 |
0.81 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51362 |
481 |
F344/DuCrl |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
urine sodium amount |
male |
87 days-120 days |
8 |
|
|
1.25 |
mEq/d |
0.19 |
0.54 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51363 |
481 |
F344/DuCrl |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
urine sodium amount |
female |
87 days-120 days |
10 |
|
|
1.24 |
mEq/d |
0.13 |
0.4 |
flame atomic emission spectrometry |
|
0 |
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51365 |
481 |
SHR/NCrl |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
6 |
|
|
17.34 |
beats/min |
5.18 |
12.69 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50985 |
481 |
SS-Chr 20BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
renin activity |
female |
87 days-120 days |
11 |
|
|
3.37 |
ng/ml/h |
0.66 |
2.2 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51004 |
481 |
SHR/NCrl |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
renin activity |
female |
87 days-120 days |
6 |
|
|
3.33 |
ng/ml/h |
0.45 |
1.11 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51011 |
481 |
SS-Chr 16BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
urine sodium amount |
male |
87 days-120 days |
8 |
|
|
1.07 |
mEq/d |
0.18 |
0.5 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51049 |
481 |
SS/JrHsdMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) then tactile electric shock exposure (2 %) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
92 days-94 days |
8 |
|
serial mean |
11.0 |
mmHg |
3.0 |
8.49 |
vascular indwelling catheter method |
left femoral artery |
0 |
|
0 |
|
|
|
|
66150 |
151 |
FHH/EurMcwi |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
renin activity |
female |
87 days-120 days |
6 |
|
|
11.87 |
ng/ml/h |
0.85 |
2.08 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50389 |
481 |
WKY/NCrl |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
male |
87 days-120 days |
9 |
|
|
0.4 |
mg/dl |
0.02 |
0.06 |
radioimmunoassay |
|
|
|
0 |
|
|
|
|
50409 |
481 |
Crl:CD(SD) |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
renin activity |
male |
87 days-120 days |
5 |
|
|
5.64 |
ng/ml/h |
1.41 |
3.16 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
50413 |
481 |
LEW/Crl |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
urine sodium amount |
female |
87 days-120 days |
7 |
|
|
1.07 |
mEq/d |
0.15 |
0.39 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
50437 |
481 |
BN/NHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (for 28 days) then controlled sodium content diet (8 %) (for 31 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 1.5 days) then controlled exposure to ambient light (for 12 hours) |
Cowley AW Jr, et al., Physiol Genomics 2000 Apr 27;2(3):107-15. |
arterial blood pressure trait |
male |
96 days
| 21 |
|
continuous mean |
96.0 |
mmHg |
3.0 |
13.75 |
vascular indwelling catheter method |
femoral artery |
10800.0 |
|
0 |
|
left femoral artery |
|
|
13275 |
229 |
SS/JrHsdMcwi |
absolute change in mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then NG-nitroarginine methyl ester (5 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
9 |
|
serial mean |
24.0 |
mmHg |
4.0 |
12.0 |
vascular indwelling catheter method |
left femoral artery |
0.0 |
|
0 |
|
|
|
|
67304 |
151 |
SS-Chr 18BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
renin activity |
female |
87 days-120 days |
2 |
|
|
1.29 |
ng/ml/h |
0.49 |
0.69 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50569 |
481 |
F344/DuCrl |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
9 |
|
|
410.92 |
beats/min |
6.97 |
20.92 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
50577 |
481 |
F344/DuCrl |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
9 |
|
|
413.17 |
beats/min |
9.33 |
28.0 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
50579 |
481 |
LEW/Crl |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
renin activity |
female |
87 days-120 days |
5 |
|
|
4.91 |
ng/ml/h |
0.65 |
1.44 |
radioimmunoassay |
|
|
|
0 |
|
|
|
|
51958 |
481 |
SS/JrHsdMcwi |
plasma total cholesterol level |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
blood cholesterol amount |
female |
92 days-94 days |
12 |
|
|
76.0 |
mg/dl |
4.4 |
15.24 |
plasma total cholesterol measurement test |
|
0.0 |
|
0 |
|
|
|
|
67290 |
151 |
BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then angiotensin II (20 ng/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
20 |
|
serial mean |
118.9 |
mmHg |
4.4 |
19.68 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
0 |
|
|
|
|
69529 |
151 |
SS/JrHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then angiotensin II (20 ng/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
13 |
|
serial mean |
131.3 |
mmHg |
4.2 |
15.14 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
0 |
|
|
|
|
69530 |
151 |
BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then norepinephrine (1 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
21 |
|
serial mean |
128.6 |
mmHg |
4.0 |
18.33 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
0 |
|
|
|
|
69537 |
151 |
BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then norepinephrine (3 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
20 |
|
serial mean |
135.6 |
mmHg |
3.2 |
14.31 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
0 |
|
|
|
|
69539 |
151 |
SS/JrHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then norepinephrine (3 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
13 |
|
serial mean |
168.4 |
mmHg |
7.0 |
25.24 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
0 |
|
|
|
|
69540 |
151 |
SS/JrHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then NG-nitroarginine methyl ester (5 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
9 |
|
serial mean |
159.0 |
mmHg |
7.1 |
21.3 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
0 |
|
|
|
|
69546 |
151 |
BN/NHsdMcwi |
timed urine volume |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
urine output |
female |
92 days-94 days |
25 |
|
|
9.86 |
ml/d |
0.4 |
2.0 |
urine volume measurement method |
|
0.0 |
|
0 |
|
|
needs ml/d default |
|
69464 |
151 |
SS/JrHsdMcwi |
urine sodium level |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
urine sodium amount |
female |
92 days-94 days |
14 |
|
|
149.5 |
mmol/l |
5.2 |
19.46 |
unspecified method |
|
0.0 |
|
0 |
|
urine sodium analysis |
|
|
69467 |
151 |
BN/NHsdMcwi |
urine sodium excretion rate |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
urine sodium amount |
female |
92 days-94 days |
22 |
|
|
0.46 |
mEq/d |
0.03 |
0.13 |
unspecified method |
|
0.0 |
|
0 |
|
urine sodium analysis |
umol/min |
|
69468 |
151 |
BN/NHsdMcwi |
urine potassium excretion rate |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
urine potassium amount |
female |
92 days-94 days |
22 |
|
|
0.88 |
mEq/d |
0.06 |
0.27 |
unspecified method |
|
0.0 |
|
0 |
|
urine potassium analysis |
umol/min |
|
69473 |
151 |
SS/JrHsdMcwi |
urine creatinine level |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
urine creatinine amount |
female |
92 days-94 days |
17 |
|
|
111.7 |
mg/dl |
10.5 |
43.29 |
urine creatinine analysis |
|
0.0 |
|
0 |
|
|
|
|
69476 |
151 |
BN/NHsdMcwi |
plasma high density lipoprotein cholesterol level |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
blood HDL cholesterol amount |
female |
92 days-94 days |
9 |
|
|
44.2 |
mg/dl |
2.2 |
6.6 |
plasma high-density lipoprotein-cholesterol measurement test |
|
0.0 |
|
0 |
|
|
|
|
69503 |
151 |
WKY |
body weight |
left anterior descending coronary artery occlusion then furosemide |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
body mass |
male |
42 days-56 days |
20 |
|
|
225.0 |
g |
3.0 |
13.42 |
body weighing method |
|
0.0 |
lad occlusion |
0 |
days |
|
|
|
100268 |
2460 |
WKY |
body weight |
left anterior descending coronary artery occlusion (for 196 days) then furosemide (10 ml/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
body mass |
male |
238 days-252 days |
20 |
|
|
583.0 |
g |
56.0 |
250.44 |
body weighing method |
|
0.0 |
lad occlusion |
196 |
days |
|
|
|
100271 |
2460 |
WKY |
heart left ventricle weight to tibia length ratio |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ramipril (1 mg/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle mass |
male |
266 days-280 days |
32 |
|
|
0.21 |
g/cm |
0.02 |
0.11 |
post excision weight measurement |
|
0.0 |
lad occlusion |
210 |
days |
|
|
|
100296 |
2460 |
WKY |
heart left ventricle fractional shortening |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-diastolic diameter |
male |
266 days-280 days |
16 |
|
|
16.8 |
% |
1.6 |
6.4 |
echocardiography |
|
0.0 |
lad occlusion |
210 |
days |
|
|
|
100304 |
2460 |
WKY |
heart left ventricle fractional shortening |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ramipril (1 mg/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-diastolic diameter |
male |
266 days-280 days |
32 |
|
|
18.0 |
% |
1.5 |
8.49 |
echocardiography |
|
0.0 |
lad occlusion |
210 |
days |
|
|
|
100305 |
2460 |
WKY |
heart left ventricle end-diastolic diameter |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-diastolic diameter |
male |
266 days-280 days |
16 |
|
|
10.8 |
mm |
0.3 |
1.2 |
echocardiography |
|
0.0 |
lad occlusion |
210 |
days |
|
|
|
100307 |
2460 |
WKY |
heart left ventricle end-systolic diameter |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ramipril (1 mg/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-systolic diameter |
male |
266 days-280 days |
32 |
|
|
8.8 |
mm |
0.3 |
1.7 |
echocardiography |
|
0.0 |
lad occlusion |
210 |
days |
|
|
|
100311 |
2460 |
WKY |
left ventricular end-systolic blood pressure |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ketamine (80 mg/kg) then xylazine (10 mg/kg) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricular blood pressure trait |
male |
266 days-280 days |
16 |
10 min mean |
continuous mean |
73.5 |
mmHg |
4.7 |
18.8 |
vascular transducer tipped catheter |
|
0.0 |
lad occlusion |
210 |
days |
|
|
|
100322 |
2460 |
WKY |
plasma creatinine level |
left anterior descending coronary artery occlusion (for 196 days) then furosemide (10 ml/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
blood creatinine amount |
male |
238 days-252 days |
6 |
|
|
0.47 |
mg/dl |
0.03 |
0.07 |
plasma creatinine analysis |
|
0.0 |
lad occlusion |
196 |
days |
|
|
|
100364 |
2460 |
SS-Chr 9BN/Mcwi |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
male |
87 days-120 days |
12 |
|
|
0.79 |
ml/min |
0.17 |
0.6 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51056 |
481 |
SS-Chr 9BN/Mcwi |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
female |
87 days-120 days |
12 |
|
|
0.56 |
ml/min |
0.15 |
0.53 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51059 |
481 |
FHH/EurMcwi |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
male |
87 days-120 days |
4 |
|
|
1.21 |
ml/min |
0.21 |
0.42 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51062 |
481 |
SS/JrHsdMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
10 |
|
|
-17.53 |
mmHg |
2.45 |
7.75 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50632 |
481 |
Crl:CD(SD) |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
male |
87 days-120 days |
6 |
|
|
2.46 |
ml/min |
0.22 |
0.54 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51256 |
481 |
F344/DuCrl |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
female |
87 days-120 days |
8 |
|
|
0.92 |
ml/min |
0.08 |
0.22 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51259 |
481 |
Crl:CD(SD) |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
5 |
|
|
0.36 |
beats/min |
7.52 |
16.81 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51262 |
481 |
FHH/EurMcwi |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
urine sodium amount |
female |
87 days-120 days |
8 |
|
|
1.74 |
mEq/d |
0.27 |
0.76 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51265 |
481 |
SHR/NCrl |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
female |
87 days-120 days |
5 |
|
|
0.29 |
mg/dl |
0.01 |
0.02 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51318 |
481 |
BN/NHsdMcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
male |
87 days-120 days |
3 |
|
|
0.29 |
mg/dl |
0.0 |
0.01 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51321 |
481 |
SS/JrHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
5 |
|
|
117.49 |
mmHg |
2.54 |
5.67 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51324 |
481 |
FHH/EurMcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
6 |
|
|
412.44 |
beats/min |
11.88 |
29.1 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51385 |
481 |
GH/OmrMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
3 |
|
|
-11.72 |
beats/min |
10.1 |
17.5 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51090 |
481 |
WKY/NCrl |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
9 |
|
|
103.89 |
mmHg |
5.5 |
16.51 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
|
50836 |
481 |
SS-Chr 9BN/Mcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
14 |
|
|
429.17 |
beats/min |
4.83 |
18.06 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50885 |
481 |
FHH/EurMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
6 |
|
|
4.58 |
beats/min |
3.9 |
9.56 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50910 |
481 |
FHH/EurMcwi |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
male |
87 days-120 days |
4 |
|
|
1.77 |
ml/min |
0.13 |
0.26 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51453 |
481 |
SHR/NCrl |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
urine sodium amount |
male |
87 days-120 days |
8 |
|
|
1.08 |
mEq/d |
0.16 |
0.45 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51521 |
481 |
BN/NHsdMcwi |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
urine sodium amount |
male |
87 days-120 days |
10 |
|
|
1.17 |
mEq/d |
0.16 |
0.49 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51527 |
481 |
FHH/EurMcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
female |
87 days-120 days |
6 |
|
|
0.27 |
mg/dl |
0.01 |
0.02 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51535 |
481 |
SS/JrHsdMcwi |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
female |
87 days-120 days |
8 |
|
|
1.36 |
ml/min |
0.12 |
0.35 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51549 |
481 |
LEW/Crl |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
4 |
|
|
352.38 |
beats/min |
10.21 |
20.42 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
|
51782 |
481 |
SS-Chr 18BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
7 |
|
|
119.18 |
mmHg |
4.9 |
12.98 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51819 |
481 |
SS-Chr 18BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
5 |
|
|
117.87 |
mmHg |
3.37 |
7.54 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
52000 |
481 |
SHR/NCrl |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
6 |
|
|
137.69 |
mmHg |
5.58 |
13.68 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
52005 |
481 |
SS/JrHsdMcwi |
creatinine clearance |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
glomerular filtration trait |
female |
92 days-94 days |
10 |
|
|
1.08 |
ml/min |
0.37 |
1.17 |
urine creatinine analysis |
|
0.0 |
|
0 |
|
|
mg/min |
|
69480 |
151 |
WKY |
plasma creatinine level |
left anterior descending coronary artery occlusion (for 196 days) then furosemide (10 ml/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
blood creatinine amount |
male |
238 days-252 days |
6 |
|
|
0.47 |
mg/dl |
0.03 |
0.07 |
plasma creatinine analysis |
|
0.0 |
lad occlusion |
196 |
days |
|
|
|
100378 |
2460 |
WKY |
heart weight |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ramipril (1 mg/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart mass |
male |
266 days-280 days |
32 |
|
|
1.44 |
g |
0.37 |
2.09 |
post excision weight measurement |
|
0.0 |
lad occlusion |
210 |
days |
|
|
|
100281 |
2460 |
WKY |
tibia length |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
tibia length |
male |
266 days-280 days |
16 |
|
|
4.3 |
cm |
0.09 |
0.36 |
post excision length measurement |
|
0.0 |
lad occlusion |
210 |
days |
|
|
|
100286 |
2460 |
WKY |
maximum rate of positive change in left ventricular blood pressure |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ramipril (1 mg/kg/d) (for 182 days) then ketamine (80 mg/kg) then xylazine (10 mg/kg) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricular blood pressure trait |
male |
266 days-280 days |
32 |
10 min mean |
continuous mean |
2882.0 |
mmHg/s |
208.0 |
1176.63 |
vascular transducer tipped catheter |
|
0.0 |
lad occlusion |
210 |
days |
|
|
|
100329 |
2460 |
WKY |
serum sodium level |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ramipril (1 mg/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
blood sodium amount |
male |
266 days-280 days |
32 |
|
|
155.1 |
mmol/l |
1.1 |
6.22 |
automated serum sodium test |
|
0.0 |
lad occlusion |
210 |
days |
|
|
|
100332 |
2460 |